Prevalence of dental fluorosis in children taking part in an oral health programme including fluoride tablet supplements from the age of 2 years

International Journal of Paediatric Dentistry
Charlotte EckerstenLars Matsson

Abstract

To investigate the prevalence of dental fluorosis in children who had participated in an oral health programme between the ages 2-5 years, including fluoride tablets from the age of 2 years. The study group consisted of 135 10- to 11-year-old children who had participated in the programme, including parent education, tooth-brushing instruction and prescribed fluoride tablets (0.25 mg NaF) (2-3 years: 1 tablet/day; 3-5 years: 2 tablets/day). The prevalence of dental fluorosis in the study group was compared with that in a nonintervention reference group consisting of 129 children of the same ages. The analysis was based on photos of the permanent maxillary front teeth using the Thylstrup & Fejerskov (TF) Index. No statistically significant difference in prevalence of dental fluorosis was seen between the two groups. Forty-three percent of the children in the study group and 38% in the reference group had fluorosis, the majority of a mild nature (TF-score 1). None had a TF score above 2. The pattern was the same after correction for parent reported intake of tablets at 3 and 5 years of age. Introduction of fluoride tablets at the age of 2 years did not result in increased prevalence of dental fluorosis.

References

Mar 1, 1988·British Journal of Industrial Medicine
Dec 1, 1982·Community Dentistry and Oral Epidemiology·A K Holm, R Andersson
Oct 3, 1998·Community Dentistry and Oral Epidemiology·A K Mascarenhas, B A Burt
Jun 6, 2002·British Dental Journal·E T TreasureJ Kleijnen
Jul 22, 2006·Community Dentistry and Oral Epidemiology·Liang HongDeborah V Dawson
May 22, 2007·Acta Odontologica Scandinavica·Lorna M D MacphersonKenneth W Stephen
Jul 27, 2007·Journal of Dental Research·L G Do, A J Spencer
Feb 2, 2008·International Journal of Paediatric Dentistry·Inger WennhallSvante Twetman
Jan 22, 2010·The Cochrane Database of Systematic Reviews·May Cm WongValeria Cc Marinho
Jul 31, 2010·Database : the Journal of Biological Databases and Curation·Jussi PaananenGarry Wong

❮ Previous
Next ❯

Citations

Apr 12, 2013·Periodontology 2000·Jeffrey L EbersoleOctavio A Gonzaléz
Apr 15, 2016·Ciência & saúde coletiva·Marcoeli Silva de MouraMarina de Deus Moura de Lima
Apr 14, 2016·Central European Journal of Public Health·Ewa RodakowskaJacek Jamiołkowski
Feb 7, 2021·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Justyna Opydo-SzymaczekBogdan Wyrwas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.